Paradigm Biopharmaceuticals Ltd.'s market cap is currently ―. The company's EPS TTM is $-0.153; its P/E ratio is -1.22; Paradigm Biopharmaceuticals Ltd. is scheduled to report earnings on August 23, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 22	Jun 21	Jun 20	Jun 19	Jun 18
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	-	-	-	-	-
EBITDA	-	-	-	-	-
Net Income Common Stockholders	-	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	AU$ 39.67M	AU$ 71.03M	AU$ 103.92M	AU$ 78.84M	AU$ 2.45M
Total Assets	AU$ 50.69M	AU$ 84.79M	AU$ 112.36M	AU$ 85.51M	AU$ 15.19M
Total Debt	AU$ 616.67K	AU$ 751.84K	AU$ 873.69K	AU$ 0.00	AU$ 0.00
Net Debt	AU$ -39.06M	AU$ -70.28M	AU$ -103.05M	AU$ -78.84M	AU$ -2.45M
Total Liabilities	AU$ 8.38M	AU$ 6.52M	AU$ 4.18M	AU$ 2.70M	AU$ 1.33M
Stockholders Equity	AU$ 42.31M	AU$ 78.27M	AU$ 108.18M	AU$ 82.81M	AU$ 13.86M
Cash Flow	-
Free Cash Flow	-	-	-	-	-
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in AUD

Paradigm Biopharmaceuticals Ltd. Earnings and Revenue History

Income Statement >

Paradigm Biopharmaceuticals Ltd. Debt to Assets

Balance Sheet >

Paradigm Biopharmaceuticals Ltd. Cash Flow

Cash Flow >

Paradigm Biopharmaceuticals Ltd. Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing